MediBeacon   Report issue

For profit Phase 1 Phase 2
Founded: St Louis MO United States (2011)
Status: No NME R&D (2011)

Organization Overview

First Clinical Trial
2013
NCT02098174
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

MediBeacon | MediBeacon, Inc. | MediBeacon, LLC